Audion Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $2.81M
Latest Deal Amount
  • Investors
  • 3

Audion Therapeutics General Information

Description

Developer of drugs and delivery technologies designed to increase the effectiveness of treating ear affecting diseases. The company's technologies are involved in the discovery of disease-intervention therapies through research into inner ear cellular biology and physiology, enabling patients who suffer from hearing loss to begin their treatment more quickly and result in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • Linnaeusparkweg 10-2
  • 1098 EA Amsterdam
  • Netherlands
+31 06 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Audion Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 24-Sep-2015 $2.81M 00.000 Completed Generating Revenue
2. Grant 08-Sep-2015 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Feb-2014 Completed Generating Revenue
To view Audion Therapeutics’s complete valuation and funding history, request access »

Audion Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs and delivery technologies designed to increase the effectiveness of treating ear affecting diseases.
Biotechnology
Amsterdam, Netherlands
00.000
00000000000 00.000

00000000

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000 000000000
Stevenage, United Kingdom
00 As of 0000
000.00
0000000000 0 000.00

0000000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000 000000000
Seattle, WA
0 As of 0000
00000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Audion Therapeutics Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Autifony Therapeutics Venture Capital-Backed Stevenage, United Kingdom 00 000.00 0000000000 0 000.00
0000000 0000000000 Accelerator/Incubator Backed Seattle, WA 0 00000 0000000000
0000000 0000000000 Venture Capital-Backed Tübingen, Germany 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
00000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
You’re viewing 5 of 15 competitors. Get the full list »

Audion Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Peter Weber MD CMO
Rolf Jan Rutten Co-Founder & Chief Executive Officer
Helmuth Van Es Ph.D Co-Founder & Chief Scientific Officer
Albert Edge Ph.D Scientific Co-Founder & Consultant
You’re viewing 4 of 5 executive team members. Get the full list »

Audion Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Inkef Capital Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
To view Audion Therapeutics’s complete investors history, request access »